Tina Paul
Adult Health · Knoxville, TNNPI 1356322341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,009 and has fallen 93.4% since, to $132 in 2025.
Across 269 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$598
- Novo Nordisk$567
- GSK$382
- AstraZeneca$324
- E.r. Squibb & Sons, L.L.C.$252
- Abbott$232
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,434100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $598 |
| Novo Nordisk | 30 | $567 |
| GSK | 26 | $382 |
| AstraZeneca | 11 | $324 |
| E.r. Squibb & Sons, L.L.C. | 15 | $252 |
| Abbott | 14 | $232 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $218 |
| Boehringer Ingelheim | 13 | $202 |
| Amarin Pharma, Inc. | 11 | $166 |
| Bayer | 11 | $158 |
| Dexcom, Inc. | 7 | $121 |
| Biohaven Pharmaceuticals, Inc. | 6 | $112 |
| Sanofi-aventis U.S. LLC | 6 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $87 |
| Medtronic | 4 | $77 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Pfizer | 4 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $63 |
| Amgen | 4 | $62 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Mylan Specialty L.p. | 4 | $57 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Merck | 2 | $31 |
| Johnson & Johnson | 2 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Radius Health, Inc. | 1 | $23 |
| Clarus Therapeutics Inc. | 2 | $19 |
| Novartis | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Scynexis, Inc. | 1 | $13 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,434 in reported general payments places this provider in the 85th percentile of 352 adult health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 47 | $60,384 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $49,450 |
| MounjaroTirzepatide | 36 | $41,037 |
| EliquisApixaban | 42 | $36,005 |
| UbrelvyUbrogepant | 19 | $34,171 |
| OzempicSemaglutide | 29 | $32,881 |
| JardianceEmpagliflozin | 32 | $32,814 |
| LinzessLinaclotide | 21 | $20,170 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $17,210 |
| XareltoRivaroxaban | 24 | $16,804 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $14,065 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $13,473 |
| BrilintaTicagrelor | 13 | $13,195 |
| GemtesaVibegron | 12 | $11,594 |
| MyrbetriqMirabegron | 16 | $11,463 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $382 | $66,66052 claims |
| MerckJanuvia | $31 | $60,38447 claims |
| AbbVieUbrelvy, Linzess | $598 | $54,34040 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $202 | $46,28644 claims |
| Lilly USA, LLCMounjaro | $29 | $41,03736 claims |
| AstraZenecaBreztri Aerosphere, Brilinta, Symbicort | $324 | $36,29343 claims |
| PfizerEliquis | $66 | $36,00542 claims |
| Novo NordiskOzempic | $567 | $32,88129 claims |
| Johnson & JohnsonXarelto | $31 | $16,80424 claims |
| Astellas Pharma US IncMyrbetriq | $55 | $11,46316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 352 adult health providers in Tennessee.
Other adult health in Knoxville
- Robbie LeinartKnoxville$48K
- Jacquelynne PrinceKnoxville$8K
- Sara JonesKnoxville$8K
- Kristy BowersKnoxville$7K
- Mary HammondsKnoxville$5K
- Sherry CoffieldKnoxville$4K
- Lauren MonroeKnoxville$4K
- Brenda BaxterNashville$246K
- Artangela HenryMemphis$74K
- Luisa LealNashville$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.